Methylamine

Methylamine

SCHEMBL6780338

CN.COc1cc2c(NC(=O)Nc3c(Cl)cccc3Cl)ncnc2cc1C#CCCCCNC(=O)OC(C)(C)C

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 2/20 0.43
HDAC4 P56524 2/20 0.43
HDAC1 Q13547 2/20 0.43
HDAC7 Q8WUI4 2/20 0.43
HDAC2 Q92769 2/20 0.43
HDAC10 Q969S8 2/20 0.43
HDAC11 Q96DB2 2/20 0.43
HDAC8 Q9BY41 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
HDAC9 Q9UKV0 2/20 0.43
HDAC5 Q9UQL6 2/20 0.43
ATM Q13315 3/20 0.41
KDR P35968 8/20 0.40
EGFR P00533 7/20 0.40
FLT1 P17948 1/20 0.39
FLT4 P35916 1/20 0.39
BRAF P15056 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
AURKB Q96GD4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6773186 0.87 HDAC3 (0.42) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL4429450 0.87 HDAC3 (0.48) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6780330 0.86 KDR (0.39) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6780346 0.85 HDAC3 (0.42) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6773188 0.82 HDAC3 (0.42) HDAC3HDAC4HDAC1HDAC7HDAC2
Methylamine SCHEMBL6776180 0.81 ATM (0.45) HDAC3HDAC4HDAC1HDAC7HDAC2
Methylamine SCHEMBL6776480 0.75 AXL (0.41) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL4423957 0.75 KDR (0.60) KDREGFRFLT1
SCHEMBL4427451 0.72 EGFR (0.52) KDREGFRBRAF
SCHEMBL7178366 0.72 HDAC3 (0.38) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6806274-B1 IMMUNOREGULATION OR IMMUNOSUPPRESSIVE AGENTS; TYROSINE KINASE INHIBITORS; PREVENTING ORGAN TRANSPLANT REJECTION; AUTOIMMUNE CONDITIONS; REDUCED SIDE EFFECTS ASTRAZENECA UK LIMITED (GB) 2004-10-19 US disclosed